INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 273 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,113 | -17.7% | 1,250 | 0.0% | 0.02% | -17.4% |
| Q2 2023 | $79,150 | +16.9% | 1,250 | 0.0% | 0.02% | +9.5% |
| Q1 2023 | $67,688 | +2.3% | 1,250 | 0.0% | 0.02% | -4.5% |
| Q4 2022 | $66,150 | +14.1% | 1,250 | 0.0% | 0.02% | 0.0% |
| Q3 2022 | $58,000 | -18.3% | 1,250 | 0.0% | 0.02% | -21.4% |
| Q2 2022 | $71,000 | -6.6% | 1,250 | 0.0% | 0.03% | +12.0% |
| Q1 2022 | $76,000 | +16.9% | 1,250 | 0.0% | 0.02% | +19.0% |
| Q4 2021 | $65,000 | +38.3% | 1,250 | 0.0% | 0.02% | +23.5% |
| Q3 2021 | $47,000 | -7.8% | 1,250 | 0.0% | 0.02% | -10.5% |
| Q2 2021 | $51,000 | +50.0% | 1,250 | +25.0% | 0.02% | +46.2% |
| Q1 2021 | $34,000 | +6.2% | 1,000 | 0.0% | 0.01% | -7.1% |
| Q4 2020 | $32,000 | +23.1% | 1,000 | 0.0% | 0.01% | +7.7% |
| Q3 2020 | $26,000 | 0.0% | 1,000 | 0.0% | 0.01% | -7.1% |
| Q2 2020 | $26,000 | +73.3% | 1,000 | 0.0% | 0.01% | +40.0% |
| Q1 2020 | $15,000 | -55.9% | 1,000 | 0.0% | 0.01% | -41.2% |
| Q4 2019 | $34,000 | +385.7% | 1,000 | 0.0% | 0.02% | +466.7% |
| Q3 2019 | $7,000 | -46.2% | 1,000 | 0.0% | 0.00% | -57.1% |
| Q2 2019 | $13,000 | +8.3% | 1,000 | 0.0% | 0.01% | +16.7% |
| Q1 2019 | $12,000 | +9.1% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $11,000 | -50.0% | 1,000 | 0.0% | 0.01% | -45.5% |
| Q3 2018 | $22,000 | +22.2% | 1,000 | 0.0% | 0.01% | +10.0% |
| Q2 2018 | $18,000 | -14.3% | 1,000 | 0.0% | 0.01% | -16.7% |
| Q1 2018 | $21,000 | +50.0% | 1,000 | 0.0% | 0.01% | +71.4% |
| Q4 2017 | $14,000 | -12.5% | 1,000 | 0.0% | 0.01% | -12.5% |
| Q3 2017 | $16,000 | +33.3% | 1,000 | 0.0% | 0.01% | +14.3% |
| Q2 2017 | $12,000 | -25.0% | 1,000 | 0.0% | 0.01% | -22.2% |
| Q1 2017 | $16,000 | +6.7% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $15,000 | 0.0% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $15,000 | -61.5% | 1,000 | 0.0% | 0.01% | -65.4% |
| Q2 2016 | $39,000 | +39.3% | 1,000 | 0.0% | 0.03% | +36.8% |
| Q1 2016 | $28,000 | -74.1% | 1,000 | -50.0% | 0.02% | -51.3% |
| Q4 2015 | $108,000 | +170.0% | 2,000 | +100.0% | 0.04% | +21.9% |
| Q3 2015 | $40,000 | +25.0% | 1,000 | 0.0% | 0.03% | +33.3% |
| Q2 2015 | $32,000 | +33.3% | 1,000 | 0.0% | 0.02% | +41.2% |
| Q1 2015 | $24,000 | +33.3% | 1,000 | 0.0% | 0.02% | +30.8% |
| Q4 2014 | $18,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |